Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans
Phase 1
Completed
- Conditions
- Insulin Resistance, Diabetes
- Interventions
- Other: Placebo capsulesOther: 2g capsulesOther: 4g capsulesOther: Water ControlOther: 2g tabletsOther: 4g tablets
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Housey Healthcare ULC
- Target Recruit Count
- 22
- Registration Number
- NCT03135015
- Locations
- 🇨🇦
Glycemic Index Laboratories, Inc., Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath